BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7863470)

  • 1. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
    Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.
    Okada K; Yuasa H; Hagiya Y; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):181-91. PubMed ID: 7863467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the kringle domain in plasminogen activation with staphylokinase.
    Arai K; Madoiwa S; Mimuro J; Asakura S; Matsuda M; Sako T; Sakata Y
    J Biochem; 1998 Jan; 123(1):71-7. PubMed ID: 9504411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.
    Mölkänen T; Tyynelä J; Helin J; Kalkkinen N; Kuusela P
    FEBS Lett; 2002 Apr; 517(1-3):72-8. PubMed ID: 12062412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the N-terminal region of staphylokinase (SAK): evidence for the participation of the N-terminal region of SAK in the enzyme-substrate complex formation.
    Rajamohan G; Dikshit KL
    FEBS Lett; 2000 Jun; 474(2-3):151-8. PubMed ID: 10838076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K; Collen D; Lijnen HR
    J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of endothelial cells on activity of staphylokinase.
    Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of staphylokinase-derived nonadecapeptide on the activation of plasminogen.
    Okada K; Ueshima S; Matsuno H; Kawao N; Okamoto C; Tanaka M; Matsuo O
    Thromb Haemost; 2007 May; 97(5):795-802. PubMed ID: 17479190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis.
    Shishido Y; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
    Biol Pharm Bull; 1994 Dec; 17(12):1595-8. PubMed ID: 7735201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.
    Grella DK; Castellino FJ
    Blood; 1997 Mar; 89(5):1585-9. PubMed ID: 9057640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.
    Sazonova IY; Robinson BR; Gladysheva IP; Castellino FJ; Reed GL
    J Biol Chem; 2004 Jun; 279(24):24994-5001. PubMed ID: 15069059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of staphylokinase concentration of plasminogen activation.
    Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional properties of recombinant staphylokinase variants obtained by site-specific mutagenesis of methionine-26.
    Schlott B; Hartmann M; Gührs KH; Birch-Hirschfeld E; Gase A; Vettermann S; Collen D; Lijnen HR
    Biochim Biophys Acta; 1994 Feb; 1204(2):235-42. PubMed ID: 8142464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
    Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
    J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
    Ries M; Zenker M
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.